Angiogenesis as a new target for cancer treatment
β Scribed by M. Ono; Hiroto Izumi; Shigeo Yoshida; Daisuke Goto; Sei-ichiro Jimi; Naoyuki Kawahara; Tadahisa Shono; Shin Ushiro; Masahiro Ryuto; Kimitoshi Kohno; Yasafumi Sato; Michihiko Kuwano
- Publisher
- Springer
- Year
- 1996
- Tongue
- English
- Weight
- 106 KB
- Volume
- 38
- Category
- Article
- ISSN
- 0344-5704
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract It is becoming increasingly clear that angiogenesis plays a crucial role in prostate cancer (CaP) survival, progression, and metastasis. Tumor angiogenesis is a hallmark of advanced cancers and an attractive treatment target in multiple solid tumors. By understanding the molecular basis
Considerable evidence is gathering for the involvement of vascular endothelial growth factor (VEGF) in the vascularization and growth of primary tumours as well as in the formation of metastases. The expression of VEGF depends on activated oncogenes and inactivated tumour suppressor genes as well as